modafinil has been researched along with scopolamine hydrobromide in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Burnham, KE; Dawson, GR; Dias, R; O'connor, D; Waters, KA | 1 |
Cai, GJ; Chu, ZX; Liu, AJ; Su, DF; Yu, XH | 1 |
Hoyt, RE; Lawson, BD; McClellan, MA; McGee, HA; Strompolis, ML | 1 |
Chen, CR; Huang, ZL; Liu, YY; Qu, WM; Urade, Y; Yang, SR | 1 |
Han, B; Liu, AJ; Liu, HQ; Song, XR; Tian, JS; Yu, XH; Zhang, LL; Zhang, Y | 1 |
Ge, J; Hong, ZY; Huang, ZL; Lazarus, M; Li, YD; Luo, YJ; Qu, WM; Wang, J; Xu, W | 1 |
1 review(s) available for modafinil and scopolamine hydrobromide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for modafinil and scopolamine hydrobromide
Article | Year |
---|---|
Modafinil as a potential motion sickness countermeasure.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Coriolis Force; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Modafinil; Motion Sickness; Muscarinic Antagonists; Scopolamine; Young Adult | 2009 |
5 other study(ies) available for modafinil and scopolamine hydrobromide
Article | Year |
---|---|
Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat.
Topics: Animals; Attention; Benzhydryl Compounds; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Modafinil; Parasympatholytics; Parasympathomimetics; Photic Stimulation; Physostigmine; Psychomotor Performance; Rats; Reaction Time; Scopolamine; Serial Learning | 2005 |
A novel animal model for motion sickness and its first application in rodents.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Defecation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Male; Mice; Modafinil; Motion Sickness; Muscarinic Antagonists; Piloerection; Rats; Rats, Sprague-Dawley; Scopolamine; Tremor; Urination | 2007 |
Roles of adrenergic α1 and dopamine D1 and D2 receptors in the mediation of the desynchronization effects of modafinil in a mouse EEG synchronization model.
Topics: Adrenergic Uptake Inhibitors; Animals; Benzhydryl Compounds; Cerebral Cortex; Cholinergic Antagonists; Cortical Synchronization; Dopamine Antagonists; Electroencephalography; Male; Mice; Modafinil; Raclopride; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Scopolamine; Wakefulness-Promoting Agents | 2013 |
The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.
Topics: Analysis of Variance; Animals; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cholinergic Antagonists; Dextroamphetamine; Diphenhydramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Granisetron; Locomotion; Male; Mice; Mice, Inbred ICR; Modafinil; Motion Sickness; Rotation; Scopolamine | 2016 |
High cortical delta power correlates with aggravated allodynia by activating anterior cingulate cortex GABAergic neurons in neuropathic pain mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Cerebral Cortex; Cholinergic Antagonists; Cortical Synchronization; Delta Rhythm; Electroencephalography; Electromyography; GABAergic Neurons; Gyrus Cinguli; Hyperalgesia; Mice; Modafinil; Neuralgia; Pain Threshold; Proto-Oncogene Proteins c-fos; Reserpine; Sciatic Nerve; Scopolamine; Sleep; Sleep Deprivation; Wakefulness-Promoting Agents | 2020 |